Assessment of Physical Activity During Therapy With Regorafenib for Metastatic Colorectal Cancer

NCT02347852 · clinicaltrials.gov ↗

COMPLETED

Status

25

Enrollment

INDUSTRY

Sponsor class

Conditions

Colorectal Neoplasms

Interventions

DRUG: Regorafenib (Stivarga, BAY73-4506)

Sponsor

Bayer